This content is machine translated New oral therapy for ulcerative colitis First selective S1P receptor modulator in gastroenterology Ozanimod offers a new treatment option for adult patients with moderate to severe active ulcerative colitis (UC) who have had an inadequate or no response to conventional therapy or a… CME-Test
View Post 1 min This content is machine translated Interdisciplinary training The new oral therapy for ulcerative colitis In the film you can retrace the entire event, including the discussion panel. CME-Test
View Post 1 min This content is machine translated Zeposia Der S1P Rezeptor-Modulator und sein Potential – Le modulateur des récepteurs de S1P et son potentiel PD Dr. med Pascal Juilerrat illustrates the mechanism of action of Zeposia® and explains the effect on the immune system during a disease with ulcerative colitis. PD Dr. med Pascal…
View Post 1 min This content is machine translated View of the effectiveness - Aperçu de l'efficacité Die TRUE NORTH Studie – L’étude TRUE NORTH Prof. Dr. med. Alain Schöpfer will guide you through the Phase 3 pivotal study of Zeposia® with focus on study design and efficacy data. Prof. Dr. med. Alain Schöpfer vous…
View Post 1 min This content is machine translated Zeposia Safety profile and tolerance – Profil de sécurité et tolerance PD. Luc Biedermann, MD, goes into more detail about the safety data from the Zeposia® studies in ulcerative colitis and puts them in the context of the mechanism of action.…
View Post 1 min This content is machine translated The S1P receptor modulation - Les modulateurs des récepteurs de S1P Experience from neurology – Expériences en neurologie PD. Robert Höpner, MD, shares his experience with Zeposia® for the treatment of multiple sclerosis, particularly with regard to safety. PD. Dr. med. Robert Höpner partage son expérience avec Zeposia®…
View Post 1 min This content is machine translated "Good meets brain" An insight into the application – Un aperçu de l’application Prof. Dr. med. Stephan Vavricka and PD Dr. med. Höpner discuss the use of Zeposia® in practice with regard to dosage, application and safety. Prof. Dr. med. Stephan Vavricka et…
View Post 1 min This content is machine translated From the clinic - De la clinique Case reports from Germany -Rapports de cas d’Allemagne Prof. Dr. med. Dominik Bettenworth presents two patient cases with Zeposia® from his practice: A young patient in whom many therapies had already failed and a patient in whom Zeposia®…
